+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Therapeutic Plasma Exchange Market - Global Forecast 2026-2032- Product Image
Therapeutic Plasma Exchange Market - Global Forecast 2026-2032- Product Image
New

Therapeutic Plasma Exchange Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 198 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5147996
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Therapeutic plasma exchange is rapidly evolving from a specialized clinical intervention to a core component across diverse specialty care areas. As both clinical and procurement leaders adapt to its shifting landscape, understanding the interdependencies between technology, supply chains, and policy is essential for resilient and value-driven decision-making.

Market Snapshot: Therapeutic Plasma Exchange Market Growth

The Therapeutic Plasma Exchange Market is demonstrating robust momentum, growing from USD 1.79 billion in 2025 to USD 1.91 billion in 2026. Continued expansion is forecast, with projections indicating a compound annual growth rate (CAGR) of 7.36% and an estimated market size reaching USD 2.95 billion by 2032. This steady growth reflects increasing adoption, clinical application expansion, and supportive technological innovation shaping the sector’s trajectory.

Scope & Segmentation

  • Clinical Indications: Covers autoimmune disorders, hematological conditions, and a rising focus on neurological diseases, each shaping procedural protocols and product selection criteria.
  • Procedure Types: Includes both centrifugation and membrane-based therapeutic plasma exchange systems, addressing complementary operational needs and influencing procurement strategies.
  • Product Segments: Encompasses devices, consumables (anticoagulants, replacement fluids, tubing sets), and comprehensive service agreements integral to end-user performance and cost planning.
  • Care Settings: Spans clinics, hospitals, and specialized plasma exchange centers, each with distinctive procurement patterns and workflow considerations.
  • Regional Markets: Examines the Americas, Europe Middle East & Africa, and Asia-Pacific, capturing differences in regulatory environments, reimbursement models, and supply priorities that affect adoption and investment decisions.
  • Technology Focus: Reviews advances such as incremental automation, design-for-localization, and modular platforms that support evolving clinical and operational requirements.

Key Takeaways for Senior Decision-Makers

  • Therapeutic plasma exchange is now driven by a blend of clinical maturity, technology advancement, and integrated service models, requiring decision-makers to balance clinical outcomes and operational reliability.
  • Expanding evidence for plasma exchange in neurological and autoimmune disorders is enabling earlier intervention and more standardized care pathways, increasing demand for validated devices and predictable supply flows.
  • Operational models differ by setting; clinics, hospitals, and specialized centers optimize device selection and procurement strategies to match workflow, cost, and protocol requirements.
  • Policy shifts and reimbursement structures increasingly tie procurement to demonstrable outcomes, with emphasis on lifecycle costs, bundled consumable contracts, and service-oriented partnerships driving supplier selection.
  • Regional nuances—such as centralized procurement in the Americas or varied regulatory frameworks in Europe, Middle East & Africa—require tailored commercial strategies for sustainable adoption.
  • Modularization of platforms and managed-service offerings provide commercial agility, supporting both operational resilience and long-term customer retention.

Tariff Impact on Therapeutic Plasma Exchange

Cumulative United States tariff measures introduced in 2025 are creating new pressures throughout therapeutic plasma exchange supply chains. Manufacturers dependent on imported components face increased costs, which may prompt adjustments in pricing strategies, supply reconfiguration, or operational efficiencies. Health systems, especially those using just-in-time inventory, are particularly sensitive to these changes, often revising contracts and extending inventory coverage to mitigate volatility.

Tariff policy also influences production footprint decisions, spurring some suppliers to relocate or diversify manufacturing to reduce tariff exposure. This may require investment and adaptation to local regulatory requirements. Meanwhile, innovation cycles may shift toward cost-optimization and modularization, supporting substitution of domestic components while maintaining compliance with medical quality benchmarks. Purchasers may respond with long-term procurement agreements and bundled models to control exposure to price volatility.

Methodology & Data Sources

This report combines a structured secondary review of clinical and regulatory sources with expert interviews from clinical, procurement, and industry stakeholders. The integration is reinforced by supply-chain mapping and triangulation against observed market behaviors, ensuring that recommendations are grounded in real-world operational realities and validated data flows.

Why This Report Matters

  • Enables leaders to navigate evolving procurement and supply-chain complexities with evidence-based, actionable recommendations for risk mitigation and value capture.
  • Offers segment-level intelligence, highlighting the most relevant clinical, operational, and commercial levers for hospitals, clinics, and suppliers.
  • Facilitates strategic alignment between product development, policy compliance, and regional market needs for sustainable program scale-up.

Conclusion

Therapeutic plasma exchange is transitioning into a dynamic, evidence-driven service model shaped by technology, policy, and global supply considerations. Stakeholders that integrate clinical outcomes with operational strategy position themselves to achieve sustainable growth and competitive advantage.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Therapeutic Plasma Exchange Market, by Procedure Type
8.1. Centrifugation TPE
8.2. Membrane TPE
9. Therapeutic Plasma Exchange Market, by Product Type
9.1. Consumables
9.1.1. Anticoagulants
9.1.2. Replacement Fluids
9.1.2.1. Albumin
9.1.2.2. Colloids
9.1.2.3. Crystalloids
9.1.2.4. Fresh Frozen Plasma
9.1.3. Tubing Sets
9.2. Devices
9.3. Kits
10. Therapeutic Plasma Exchange Market, by Application
10.1. Autoimmune Disorders
10.2. Hematological Disorders
10.3. Neurological Disorders
10.3.1. Chronic Inflammatory Demyelinating Polyneuropathy
10.3.2. Guillain-Barré Syndrome
10.3.3. Multiple Sclerosis
10.3.4. Myasthenia Gravis
10.4. Renal Disorders
11. Therapeutic Plasma Exchange Market, by End User
11.1. Clinics
11.2. Hospitals
11.3. Specialized Centers
12. Therapeutic Plasma Exchange Market, by Payer Type
12.1. Public Health Insurance
12.2. Private Health Insurance
13. Therapeutic Plasma Exchange Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Therapeutic Plasma Exchange Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Therapeutic Plasma Exchange Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Therapeutic Plasma Exchange Market
17. China Therapeutic Plasma Exchange Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Asahi Kasei Medical Co., Ltd.
18.6. B. Braun Melsungen AG
18.7. Baxter International Inc.
18.8. Cerus Corporation
18.9. Fresenius Kabi AG
18.10. Grifols, S.A.
18.11. Haemonetics Corporation
18.12. Kaneka Corporation
18.13. MacoPharma S.A.
18.14. Nipro Corporation
18.15. Otsuka Holdings Co., Ltd.
18.16. Terumo Corporation
List of Figures
FIGURE 1. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PAYER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CENTRIFUGATION TPE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CENTRIFUGATION TPE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CENTRIFUGATION TPE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MEMBRANE TPE, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MEMBRANE TPE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MEMBRANE TPE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY ANTICOAGULANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY ANTICOAGULANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY ANTICOAGULANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY ALBUMIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY ALBUMIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY ALBUMIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COLLOIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COLLOIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COLLOIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CRYSTALLOIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CRYSTALLOIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CRYSTALLOIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY FRESH FROZEN PLASMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY FRESH FROZEN PLASMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY FRESH FROZEN PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TUBING SETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TUBING SETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY TUBING SETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GUILLAIN-BARRÉ SYNDROME, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GUILLAIN-BARRÉ SYNDROME, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GUILLAIN-BARRÉ SYNDROME, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MULTIPLE SCLEROSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MULTIPLE SCLEROSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MYASTHENIA GRAVIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MYASTHENIA GRAVIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY MYASTHENIA GRAVIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY RENAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY SPECIALIZED CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY SPECIALIZED CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY SPECIALIZED CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PUBLIC HEALTH INSURANCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PUBLIC HEALTH INSURANCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PUBLIC HEALTH INSURANCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRIVATE HEALTH INSURANCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRIVATE HEALTH INSURANCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRIVATE HEALTH INSURANCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 87. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 88. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 89. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2032 (USD MILLION)
TABLE 91. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 92. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 93. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 94. AMERICAS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
TABLE 95. NORTH AMERICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. NORTH AMERICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 101. NORTH AMERICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 102. NORTH AMERICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. LATIN AMERICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 106. LATIN AMERICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 108. LATIN AMERICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2032 (USD MILLION)
TABLE 109. LATIN AMERICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 111. LATIN AMERICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 112. LATIN AMERICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2032 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
TABLE 122. EUROPE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. EUROPE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 124. EUROPE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 125. EUROPE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 126. EUROPE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2032 (USD MILLION)
TABLE 127. EUROPE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 128. EUROPE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 129. EUROPE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 130. EUROPE THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
TABLE 131. MIDDLE EAST THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. MIDDLE EAST THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 133. MIDDLE EAST THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 134. MIDDLE EAST THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 135. MIDDLE EAST THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2032 (USD MILLION)
TABLE 136. MIDDLE EAST THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 137. MIDDLE EAST THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 138. MIDDLE EAST THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 139. MIDDLE EAST THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
TABLE 140. AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 142. AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 143. AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 144. AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2032 (USD MILLION)
TABLE 145. AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 146. AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 147. AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 148. AFRICA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
TABLE 149. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 159. ASEAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. ASEAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 161. ASEAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 162. ASEAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 163. ASEAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2032 (USD MILLION)
TABLE 164. ASEAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 165. ASEAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 166. ASEAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 167. ASEAN THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
TABLE 168. GCC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. GCC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 170. GCC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 171. GCC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 172. GCC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2032 (USD MILLION)
TABLE 173. GCC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 174. GCC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 175. GCC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 176. GCC THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
TABLE 177. EUROPEAN UNION THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 178. EUROPEAN UNION THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 179. EUROPEAN UNION THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 180. EUROPEAN UNION THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 181. EUROPEAN UNION THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
TABLE 186. BRICS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. BRICS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 188. BRICS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 189. BRICS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 190. BRICS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2032 (USD MILLION)
TABLE 191. BRICS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 192. BRICS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 193. BRICS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 194. BRICS THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
TABLE 195. G7 THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 196. G7 THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 197. G7 THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 198. G7 THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 199. G7 THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2032 (USD MILLION)
TABLE 200. G7 THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 201. G7 THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 202. G7 THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 203. G7 THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
TABLE 204. NATO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. NATO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 206. NATO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 207. NATO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 208. NATO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2032 (USD MILLION)
TABLE 209. NATO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 210. NATO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 211. NATO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 212. NATO THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
TABLE 213. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 214. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 215. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 216. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 217. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 218. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2032 (USD MILLION)
TABLE 219. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 220. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 221. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 222. UNITED STATES THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)
TABLE 223. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 224. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
TABLE 225. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 226. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 227. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY REPLACEMENT FLUIDS, 2018-2032 (USD MILLION)
TABLE 228. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 229. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 230. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 231. CHINA THERAPEUTIC PLASMA EXCHANGE MARKET SIZE, BY PAYER TYPE, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Therapeutic Plasma Exchange market report include:
  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Cerus Corporation
  • Fresenius Kabi AG
  • Grifols, S.A.
  • Haemonetics Corporation
  • Kaneka Corporation
  • MacoPharma S.A.
  • Nipro Corporation
  • Otsuka Holdings Co., Ltd.
  • Terumo Corporation

Table Information

Report AttributeDetails
No. of Pages198
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.91 Billion
Forecasted Market Value ( USD ) by 2032 $ 2.95 Billion
Compound Annual Growth Rate7.3%
Regions CoveredGlobal
No. of Companies Mentioned13

Related Topics

Related Reports

Therapeutic Plasma Exchange Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Therapeutic Plasma Exchange Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Therapeutic Plasma Exchange Market Report 2025 - Product Image

Therapeutic Plasma Exchange Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Therapeutic Plasma Exchange - Global Strategic Business Report - Product Image

Therapeutic Plasma Exchange - Global Strategic Business Report

  • Report
  • 197 Pages
  • Global
From
Plasma Fractionation Market - Global Forecast 2026-2032 - Product Image

Plasma Fractionation Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Plasma Therapy Market - Global Forecast 2026-2032 - Product Image

Plasma Therapy Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From

About the Therapeutic Plasma Exchange Market

Therapeutic Plasma Exchange (TPE) is a process used in blood banking to treat a variety of medical conditions. It involves the removal of plasma from a patient's blood and replacing it with donor plasma or a plasma substitute. The process is used to treat conditions such as autoimmune diseases, thrombotic thrombocytopenic purpura, and hemolytic anemia. It is also used to remove antibodies and other substances from the blood that can cause adverse reactions. TPE is a specialized procedure that requires specialized equipment and trained personnel. It is typically performed in a hospital or clinic setting. The process is usually done in a series of treatments, with the number of treatments depending on the condition being treated. The TPE market is a growing segment of the blood banking industry. It is a highly specialized field that requires specialized equipment and personnel. Companies in the market include Haemonetics Corporation, Fresenius Kabi, Terumo BCT, and Asahi Kasei Medical. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.